Optimizing therapy: tazarotene in combination with phototherapy

Area of Science:

• Dermatology
• Photomedicine

Background:

• Phototherapy is a common psoriasis treatment, often combined with other therapies to enhance efficacy and reduce radiation exposure.
• While combination therapies aim for better outcomes, they can introduce additional safety and tolerability concerns.

Purpose of the Study:

• To investigate the efficacy of combining tazarotene with ultraviolet B (UVB) phototherapy for psoriasis treatment.
• To assess if tazarotene can improve phototherapy effectiveness and potentially reduce required UV exposure without significant adverse effects.

Main Methods:

• A clinical trial involving 10 patients with psoriasis.
• Comparison of UVB phototherapy alone, UVB plus vehicle gel, and UVB plus tazarotene.

Main Results:

• The combination of UVB and tazarotene increased treatment success rates from 60% to 100% by Day 81.
• UVB plus tazarotene demonstrated superior reduction in plaque elevation and scaling compared to UVB alone or with vehicle.
• Initial treatment success was achieved in approximately half the time with the tazarotene combination (median 32 days) versus phototherapy alone (median 67 days).

Conclusions:

• Combining UVB phototherapy with tazarotene is a more efficacious and faster treatment option for psoriasis than UVB phototherapy alone.
• This combination therapy presents a valuable therapeutic strategy for managing difficult-to-treat psoriatic plaques.